Correction to: A Multicenter Double-Blind,Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder,by Strawn et al. J Child Adolesc Psychopharmacol 2023;33(3):91–100;doi: 10.1089/cap.2023.0004

In the April 2023 issue of Journal of Child and Adolescent Psychopharmacology (vol. 33, no. 3; pp. 91–100) the article entitled “A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder” by Strawn et al. requires correction.

This article was originally published under the copyright of Mary Ann Liebert, Inc. publishers. It has now been updated to reflect Open Access, with copyright transferring to the author(s), and a Creative Commons License (CC-BY) added (http://creativecommons.org/licenses/by/4.0). The CC-BY license goes into effect May 26, 2023.

The online version of this article has been corrected to reflect this.